½ÃÀ庸°í¼­
»óǰÄÚµå
1602836

¼¼°èÀÇ Ç×±Õ ¼ººÐ ½ÃÀå : À¯Çüº°, ÃÖÁ¾ »ç¿ëÀÚº° - ¿¹Ãø(2025-2030³â)

Antimicrobial Ingredients Market by Type (Inorganic, Organic), End-User (Automotive & Transportation, Building & Construction, Food & Beverage) - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 199 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Ç×±Õ ¼ººÐ ½ÃÀåÀº 2023³â¿¡ 44¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 47¾ï ´Þ·¯·Î ÃßÁ¤µÇ¸ç, CAGR 6.79%·Î ¼ºÀåÇÒ Àü¸ÁÀ̰í, 2030³â¿¡´Â 70¾ï ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

Ç×±Õ ¼ººÐÀÇ ¹üÀ§¿Í Á¤ÀÇ¿¡´Â ¹ÚÅ׸®¾Æ, ¹ÙÀÌ·¯½º, Áø±Õ µî ¹Ì»ý¹°ÀÇ ¼ºÀåÀ» ¾ïÁ¦ÇÏ´Â È­ÇÕ¹°ÀÌ Æ÷ÇԵ˴ϴÙ. ÀÌ·¯ÇÑ ¼ººÐÀº ÀǾàǰ, ½Äǰ, ÆÛ½º³ÎÄÉ¾î ¹× ÀÇ·á ºÎ¹® Á¦Ç°ÀÇ ¾ÈÀü°ú È¿°ú¸¦ À¯ÁöÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ±× Çʿ伺Àº À§»ý°ú ¾ÈÀü¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡, °¨¿°ÀÇ À¯Çà, Á¦Ç° ¹èÇÕÀ» °ü¸®ÇÏ´Â ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØ¿¡ ÀÇÇØ °­Á¶µË´Ï´Ù. ÀÌ·¯ÇÑ ¼ººÐÀÇ ¿ëµµ´Â Æø³Ð°Ô º´¿ø, ½Äǰ °¡°ø ÀåÄ¡, ¼ÒºñÀç Á¦Á¶ µî ´Ù¾çÇÑ ÃÖÁ¾ ÀÌ¿ë »ê¾÷¿¡¼­ »ì±ÕÁ¦, ¹æºÎÁ¦, Ä¡·á¿¡ À̸£°í ÀÖ½À´Ï´Ù. ½ÃÀå ÀλçÀÌÆ®¿¡ µû¸£¸é ÁÖ¿ä ¼ºÀå ¿äÀÎÀ¸·Î´Â õ¿¬ ¹× Áö¼Ó °¡´ÉÇÑ Ç×±Õ ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä ±ÞÁõ, ¼ººÐ ÇÕ¼º ±â¼ú Áøº¸, Ȱ¹ßÇÑ ¿¬±¸°³¹ß Ȱµ¿ µîÀÌ ÀÖ½À´Ï´Ù. ¶ÇÇÑ COVID-19ÀÇ ´ëÀ¯ÇàÀº À§»ý´ëÃ¥ÀÇ °­È­¿Í ¼ÒºñÀÚ °Ç°­ÀǽÄÀÇ °íÁ¶¿¡ µû¶ó ½ÃÀå ¼ö¿ä¸¦ Áõ´ë½ÃÄÑ ½ÃÀå ÁøÃâ±â¾÷°ú ±âÁ¸ ±â¾÷ÀÌ Á¦Ç° Æ÷Æ®Æú¸®¿À¸¦ Çõ½Å ¹× È®´ëÇÒ ¼ö ÀÖ´Â Å« ±âȸ¸¦ °¡Á®¿À°í ÀÖ½À´Ï´Ù. ±×·¯³ª ±ÔÁ¦»óÀÇ Àå¾Ö¹°, ±âÁ¸ÀÇ Ç×±ÕÁ¦¿¡ ´ëÇÑ ¹Ì»ý¹°ÀÇ ³»¼º ½ÅÈï±¹ ½ÃÀåÀÇ °³Ã´, È­ÇÐÁ¦Ç°À» º£À̽º·Î ÇÏ´Â ¼±ÅûçÇ×ÀÇ ºÎÀÛ¿ëÀ̳ª µ¶¼ºÀÇ °¡´É¼º µîÀÇ °úÁ¦µµ ÀÖ½À´Ï´Ù. ƯÈ÷ ±ÔÁ¦ ÇÁ·¹ÀÓ¿öÅ©°¡ ½ÉÇÑ Áö¿ª¿¡¼­´Â Á¦Ç°ÀÇ ½ÂÀÎÀ̳ª »ó¾÷È­¸¦ ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¼ºÀå ±âȸ¸¦ Ȱ¿ëÇϱâ À§ÇØ ±â¾÷Àº õ¿¬ Ç×±ÕÁ¦ÀÇ Çõ½ÅÀûÀÎ ¿ëµµ¿¡ ÃÊÁ¡À» ¸ÂÃß°í Áö¼Ó °¡´ÉÇÏ°í µ¶¼ºÀÌ ³·Àº ´ëü¹°¿¡ ´ëÇÑ ¿¬±¸¿¡ ÅõÀÚÇϰí Àü·«Àû ÆÄÆ®³Ê½ÊÀ» ¸Î°í Àü ¼¼°è ºñÁî´Ï½º °³¹ßÀ» µµ¸ðÇØ¾ß ÇÕ´Ï´Ù. ¶ÇÇÑ, È¿À²¼ºÀ» Çâ»ó½Ã۱â À§ÇÑ ±â¼ú·ÂÀ» °­È­ÇÏ°í ´Ù±â´É Ç×±ÕÁ¦¸¦ °³¹ßÇÔÀ¸·Î½á °æÀïÀ» Çâ»ó½Ãų ¼ö ÀÖ½À´Ï´Ù. ÀÌ ½ÃÀåÀº ȯ°æ ģȭÀûÀÎ ¼ÒºñÀÚ¿¡°Ô ¾ÈÀüÇÑ Á¦Ç°À¸·ÎÀÇ ÀüȯÀ» Ư¡À¸·Î ÇÏ¸ç »ýºÐÇØ¼º Ç×±ÕÁ¦ ¹× ½Ä¹° À¯·¡ Ç×±ÕÁ¦ÀÇ ±â¼ú Çõ½Å°ú ¿¬±¸°¡ À¯¸®ÇÑ ÇÁ·ÐƼ¾îÀÓÀ» º¸¿©ÁÝ´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ (2023³â) 44¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2024³â) 47¾ï ´Þ·¯
¿¹Ãø³â(2030³â) 70¾ï ´Þ·¯
CAGR(%) 6.79%

½ÃÀå ¿ªÇÐ : ºü¸£°Ô ÁøÈ­ÇÏ´Â Ç×±Õ ¼ººÐ ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

Ç×±Õ ¼ººÐ ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ ½ÃÀå ¿ªÇÐÀÇ ÁøÈ­¸¦ ÀÌÇØÇÔÀ¸·Î½á ±â¾÷Àº ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÅõÀÚ°áÁ¤, Àü·«Àû °áÁ¤ Á¤¹ÐÈ­, »õ·Î¿î ºñÁî´Ï½º ±âȸ ȹµæ¿¡ ´ëºñÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦Àû ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ» »Ó¸¸ ¾Æ´Ï¶ó, ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë ¶Ç´Â ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • °Ç°­°ú À§»ý ¹®Á¦¿¡ ´ëÇÑ ÀÇ½Ä Áõ°¡
    • »ì±ÕÁ¦¿Í Ç¥¸é ¼Òµ¶Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡
    • °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í Ç×±Õ È­ÀåǰÀÇ Ã¤¿ë·ü »ó½Â
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • Ç×±Õ ¼ººÐÀÇ ¿ø·á¿Í Á¦Á¦¿Í °ü·ÃµÈ ºñ¿ë »ó½Â
  • ½ÃÀå ±âȸ
    • ½Ä¹° À¯·¡ÀÇ Ç×±Õ Á¦Ç°¿¡ ´ëÇÑ °æÇâ
    • ½Å±Ô °³¹ß Ç×±Õ ¼ººÐÀÇ Ãâ½Ã
  • ½ÃÀåÀÇ °úÁ¦
    • Ç×±Õ ¼ººÐÀÇ ¾ö°ÝÇÑ ½ÂÀÎ ÇÁ·Î¼¼½º

Porter's Five Forces : Ç×±Õ ¼ººÐ ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â Ç×±Õ ¼ººÐ ½ÃÀå °æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» ÆÇ´ÜÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÀλçÀÌÆ®¸¦ ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : Ç×±Õ ¼ººÐ ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº Ç×±Õ ¼ººÐ ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇϴµ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : Ç×±Õ ¼ººÐ ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

Ç×±Õ ¼ººÐ ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ º¥´õÀÇ ½ÇÀûÀ» Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í °ø±Þ¾÷ü´Â °æÀïÀÌ Ä¡¿­ÇØÁö¸é¼­ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : Ç×±Õ ¼ººÐ ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â Ç×±Õ ¼ººÐ ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ÀÌ ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ºñÁî´Ï½º Á¶Á÷Àº °ø±Þ¾÷üÀÇ ºñÁî´Ï½º Àü·«°ú Á¦Ç° ¸¸Á·µµ¸¦ ±âÁØÀ¸·Î Æò°¡ÇÏ¿© ¸ñÇ¥¿¡ ¸Â´Â ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ °ø±Þ¾÷ü¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÎ¹®È­Çϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : Ç×±Õ ¼ººÐ ½ÃÀå¿¡¼­ ¼º°øÀ» À§ÇÑ ±æÀ» ±×¸®±â

Ç×±Õ ¼ººÐ ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÔ´Ï´Ù. ÁÖ¿ä ÀÚ¿ø, ´É·Â ¹× ¼º°ú ÁöÇ¥¸¦ °ËÅäÇÔÀ¸·Î½á ±â¾÷Àº ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í °³¼±À» À§ÇØ ³ë·ÂÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Á¢±Ù ¹æ½ÄÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ ´Ù·ç´Â ½ÃÀå¿¡ ´ëÇÑ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ : ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·ÂÀ» Æò°¡ÇÕ´Ï´Ù.

2. ½ÃÀå °³Ã´µµ : ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇϰí, ±âÁ¸ ºÎ¹®¿¡¼­ÀÇ È®Àå °¡´É¼ºÀ» Æò°¡Çϸç, ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» ¼³¸íÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­ : ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, »ê¾÷ÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, ¿¬±¸°³¹ß Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¾òÀº ÈÄ ÀÇ»ç°áÁ¤ÇÒ ¼ö ÀÖµµ·Ï Áß¿äÇÑ Áú¹®¿¡µµ ´ë´äÇϰí ÀÖ½À´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð ¹× ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ ¹× ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À² ¹× °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ ¹× ö¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • °Ç°­°ú À§»ý ¹®Á¦¿¡ ´ëÇÑ ÀÇ½Ä Çâ»ó
      • ¼Òµ¶Á¦¿Í Ç¥¸é ¼Òµ¶Á¦ ¼ö¿ä Áõ°¡
      • °¡Ã³ºÐ ¼Òµæ Áõ°¡¿Í Ç×±Õ È­ÀåǰÀÇ Ã¤¿ë Áõ°¡
    • ¾ïÁ¦¿äÀÎ
      • ¿ø·á³ª Ç×±Õ ¼ººÐÀÇ ¹èÇÕ¿¡ °ü·ÃÇÏ´Â ºñ¿ë »ó½Â
    • ±âȸ
      • ½Ä¹° À¯·¡ÀÇ Ç×±Õ Á¦Ç°¿¡ ´ëÇÑ °æÇâ
      • »õ·Ó°Ô °³¹ßµÈ Ç×±Õ ¼ººÐÀÇ ¹ß¸Å
    • °úÁ¦
      • Ç×±Õ ¼ººÐÀÇ ¾ö°ÝÇÑ ½ÂÀÎ ÇÁ·Î¼¼½º
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡
    • °æÁ¦
    • »çȸ
    • ±â¼ú
    • ¹ý·ü
    • ȯ°æ

Á¦6Àå Ç×±Õ ¼ººÐ ½ÃÀå : À¯Çüº°

  • ¼­¹®
  • ¹«±â
  • À¯±â

Á¦7Àå Ç×±Õ ¼ººÐ ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¼­¹®
  • ÀÚµ¿Â÷ ¹× ¿î¼Û
  • °ÇÃà ¹× °Ç¼³
  • À½½Ä
  • ÀÇ·á
  • ¼¶À¯

Á¦8Àå ¾Æ¸Þ¸®Ä«ÀÇ Ç×±Õ ¼ººÐ ½ÃÀå

  • ¼­¹®
  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦9Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ Ç×±Õ ¼ººÐ ½ÃÀå

  • ¼­¹®
  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦10Àå À¯·´, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ Ç×±Õ ¼ººÐ ½ÃÀå

  • ¼­¹®
  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦11Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼®(2023³â)
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º(2023³â)
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼® ¹× Á¦¾È

±â¾÷ ¸ñ·Ï

  • Ashland Global Holdings Inc
  • Avient Corporation
  • BASF SE
  • BioCote Limited
  • Clariant AG
  • Croda International PLC
  • Destiny Pharma PLC
  • DuPont de Nemours, Inc.
  • HeiQ PLC
  • Kemin Industries, Inc.
  • Lonza Group AG
  • LyondellBasell Industries Holdings BV
  • Merck KGaA
  • Microban International, Ltd.
  • Milliken & Company
  • Momentive Performance Materials Inc
  • NATUREX SA
  • Nouryon Chemicals Holding BV
  • Pfizer Inc.
  • RTP Company
  • Sanitized AG
  • Solvay SA
  • Stepan Company
  • Symrise AG
  • Wacker Chemie AG
AJY 24.12.13

The Antimicrobial Ingredients Market was valued at USD 4.42 billion in 2023, expected to reach USD 4.70 billion in 2024, and is projected to grow at a CAGR of 6.79%, to USD 7.00 billion by 2030.

The scope and definition of antimicrobial ingredients encompass compounds that inhibit the growth of microorganisms such as bacteria, viruses, and fungi. These ingredients are crucial in preserving the safety and efficacy of products in pharmaceuticals, food and beverages, personal care, and healthcare sectors. Their necessity is underscored by rising awareness of hygiene and safety, the increasing prevalence of infectious diseases, and stringent regulatory standards governing product formulations. Applications of these ingredients are broad, spanning disinfectants, preservatives, and therapeutic agents in diverse end-use industries like hospitals, food processing units, and consumer goods manufacturing. Market insights reveal that key growth influencers include the surging demand for natural and sustainable antimicrobial solutions, technological advancements in ingredient synthesis, and robust research and development activities. The COVID-19 pandemic has also augmented market demand due to heightened sanitation measures and a rise in consumer health consciousness, presenting significant opportunities for market entrants and established players to innovate and expand their product portfolios. However, the market is challenged by factors such as regulatory hurdles, the development of resistance by microorganisms against conventional antimicrobials, and the potential side effects or toxicity of some chemical-based options. Limitations are particularly pertinent in regions with stringent regulatory frameworks, which can impede product approvals and commercialization. To capitalize on growth opportunities, businesses should focus on innovative applications of natural antimicrobials, invest in research for sustainable and less toxic alternatives, and engage in strategic partnerships to expand their global reach. Furthermore, enhancing technological capabilities for improved efficacy and developing multi-functional antimicrobials can provide a competitive edge. The market is characterized by a shift towards environmentally friendly and consumer-safe products, indicating a lucrative frontier for innovation and research in biodegradable and plant-based antimicrobials.

KEY MARKET STATISTICS
Base Year [2023] USD 4.42 billion
Estimated Year [2024] USD 4.70 billion
Forecast Year [2030] USD 7.00 billion
CAGR (%) 6.79%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Antimicrobial Ingredients Market

The Antimicrobial Ingredients Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing awareness regarding health and hygiene issues
    • Growing demand for sanitizers and surface disinfectants
    • Rise in disposable income and higher adoption of antimicrobial cosmetic products
  • Market Restraints
    • Rising costs associated with raw materials and formulation of antimicrobial ingredients
  • Market Opportunities
    • Inclination toward plant-based antimicrobial products
    • Launch of newly developed antimicrobial ingredients
  • Market Challenges
    • Stringent approval processes of antimicrobial ingredients

Porter's Five Forces: A Strategic Tool for Navigating the Antimicrobial Ingredients Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Antimicrobial Ingredients Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Antimicrobial Ingredients Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Antimicrobial Ingredients Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Antimicrobial Ingredients Market

A detailed market share analysis in the Antimicrobial Ingredients Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Antimicrobial Ingredients Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Antimicrobial Ingredients Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Antimicrobial Ingredients Market

A strategic analysis of the Antimicrobial Ingredients Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Antimicrobial Ingredients Market, highlighting leading vendors and their innovative profiles. These include Ashland Global Holdings Inc, Avient Corporation, BASF SE, BioCote Limited, Clariant AG, Croda International PLC, Destiny Pharma PLC, DuPont de Nemours, Inc., HeiQ PLC, Kemin Industries, Inc., Lonza Group AG, LyondellBasell Industries Holdings B.V., Merck KGaA, Microban International, Ltd., Milliken & Company, Momentive Performance Materials Inc, NATUREX SA, Nouryon Chemicals Holding B.V., Pfizer Inc., RTP Company, Sanitized AG, Solvay SA, Stepan Company, Symrise AG, and Wacker Chemie AG.

Market Segmentation & Coverage

This research report categorizes the Antimicrobial Ingredients Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Inorganic and Organic.
  • Based on End-User, market is studied across Automotive & Transportation, Building & Construction, Food & Beverage, Healthcare, and Textile.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing awareness regarding health and hygiene issues
      • 5.1.1.2. Growing demand for sanitizers and surface disinfectants
      • 5.1.1.3. Rise in disposable income and higher adoption of antimicrobial cosmetic products
    • 5.1.2. Restraints
      • 5.1.2.1. Rising costs associated with raw materials and formulation of antimicrobial ingredients
    • 5.1.3. Opportunities
      • 5.1.3.1. Inclination toward plant-based antimicrobial products
      • 5.1.3.2. Launch of newly developed antimicrobial ingredients
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent approval processes of antimicrobial ingredients
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Antimicrobial Ingredients Market, by Type

  • 6.1. Introduction
  • 6.2. Inorganic
  • 6.3. Organic

7. Antimicrobial Ingredients Market, by End-User

  • 7.1. Introduction
  • 7.2. Automotive & Transportation
  • 7.3. Building & Construction
  • 7.4. Food & Beverage
  • 7.5. Healthcare
  • 7.6. Textile

8. Americas Antimicrobial Ingredients Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Antimicrobial Ingredients Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Antimicrobial Ingredients Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Ashland Global Holdings Inc
  • 2. Avient Corporation
  • 3. BASF SE
  • 4. BioCote Limited
  • 5. Clariant AG
  • 6. Croda International PLC
  • 7. Destiny Pharma PLC
  • 8. DuPont de Nemours, Inc.
  • 9. HeiQ PLC
  • 10. Kemin Industries, Inc.
  • 11. Lonza Group AG
  • 12. LyondellBasell Industries Holdings B.V.
  • 13. Merck KGaA
  • 14. Microban International, Ltd.
  • 15. Milliken & Company
  • 16. Momentive Performance Materials Inc
  • 17. NATUREX SA
  • 18. Nouryon Chemicals Holding B.V.
  • 19. Pfizer Inc.
  • 20. RTP Company
  • 21. Sanitized AG
  • 22. Solvay SA
  • 23. Stepan Company
  • 24. Symrise AG
  • 25. Wacker Chemie AG
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦